Clinical and epidemiological background of combined strategy for cervical screening of women in Ukraine

Authors

  • S Soloviov National Medical Academy of Postgraduate Education named after P.L. Shupik, Kiev, Ukraine.,
  • H Artemchuk National Medical Academy of Postgraduate Education named after P.L. Shupik, Kiev, Ukraine.,
  • O Kovalyuk National Medical Academy of Postgraduate Education named after P.L. Shupik, Kiev, Ukraine.,
  • I Dzyublyk National Medical Academy of Postgraduate Education named after P.L. Shupik, Kiev, Ukraine.,

Keywords:

diagnostic screening strategy, cervical cancer, utility function, HPV testing, cytological smear.

Abstract

Background: cervical cancer (CC) ranks second place among cancers of women of reproductive age in Ukraine, accounting for more than 2000 deaths annually. Virtually all cases of CCs are caused by persistent infection with Human Papillomaviruses (HPVs). Two main methods of diagnosis in screening for cervical pathology are cytological test (Pap-test) and molecular-genetic (HPV-test) tests. Implementation of efficient cervical cancer screening programs, based on Pap- and HPV-tests, might significantly decrease CC incidence rates. Issue of effective combination of the two diagnostic methods and development of optimal screening strategies is essential. The primary need is the development and application of pharmacoeconomic models to compare two or more diagnostic techniques (methods). This approach could be used as a tool to select more appropriate strategy given its cost and effectiveness, or utility. The main criterion of the "cost - utility" method is utility function of each diagnostic technology. The first step in constructing this model should be the definition of its basic parameters, that is the probability of HPV infection and the presence of subclinical or clinical manifestations in women at a certain age and to identify the utility function for each diagnostic test and their combinations thereof. Objective of the study was the definition of utility functions of combined strategy using HPV- and cytological tests based on clinical and epidemiological research data.

Materials and methods: 1257 cervical smears from Ukrainian women aged 19 – 65 were tested (HPV typing test and cytological testing). "Cost-utility"-based analysis and evaluation are based on the results of own clinical and laboratory studies of 1257 cervical samples (HPV DNA tests and cytological diagnostics) from women aged 19 – 65 (mean age 30.68 (±7.72)), living in different regions of Ukraine. Statistical and mathematical methods are used for modeling the utility function of a number of diagnostic strategies. Obtained results of laboratory testing formed the basis for developing screening strategies, with HPV test only, cytological test only or both tests depending on the differences in clinical and epidemiological history of the patient were evaluated.

Results: According to the results of clinical and epidemiological studies defined utility function for each test as components of a comprehensive strategy, the first step in developing an optimal algorithm for screening of HPV-associated cervical diseases in Ukraine. Simulation shows maximum of diagnostic utility for HPV test, as a single screening strategy, in women aged 29-30 years. Screening with cytological test only increases its utility with the increase of patients’ age. Combined screening strategy based on both HPV and cytological tests shows maximum of utility for HPV test when using it among younger women (<21 years old) and for cytological test when using it with women aged >21. The results will be the basis for further comprehensive assessment of screening strategies for HPV-associated lesions of the cervix.

Conclusions: Obtained results compose the first step in the development of an optimal algorithm for HPV-associated cervical screening in Ukraine. The results will form the basis for further comprehensive assessment of screening strategies.

References

Worldwide burden of cervical cancer in 2008 / Arbyn M., Castellsagué X. [et al] // Ann Oncol.  2011. N 22 (12). – P. 2675-2686.

Bruni, L. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 2015-04-08.

Statistical data from the National Cancer Registry of Ukraine [Electronic document]. - Access mode: http://www.ncru.inf.ua/publications/index.htm

Natural History of Progression of HPV Infection to Cervical Lession or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study / U. Jaisamrarn, X. Castellsague, S.M. Garland [et al] // PLoS One. – 2013. – N 8(11).- P. e79260.

Chan, P.K.S. Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies / P.K.S. Chan // Int. J. Cancer.  2010.  N 126.  P. 297–301.

Zur Hausen, H. Papillomavirus infections—a major cause of human cancers / H. Zur Hausen // Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. – 1996. – Т. 1288. – N 2. – P. F55-F78.

Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening / P. Naucler, W. Ryd, S. Törnberg [et al] // JNCI.  2009.  N 101 (2).  P. 88-99.

Ronco G. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials / G. Ronco // Lancet. - 2014. – 383. – P. 524–532.

New aspects of laboratory diagnosis of HPV infection / Kovalyuk O.V., Dzyublyk I.V., Kostenko I.G. [et al.] // Laboratory Diagnostics.-2012.- N 2(60).- P. 28-34.

Moyer, VA. Preventive Services Task Force. Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement / VA. Moyer // Annals of Internal Medicine.-2012.- N 156(12).- P. 880-891.

Filippenko, N.G. Methodological aspects of clinical and economic studies: methodical recommendations for students, residents, physicians and pharmacists / N.G. Filippenko, S.V. Povetkin // KSMU. - Kursk: KSMU, 2003 – 20 p.

Pharmacoeconomic analysis for evaluation of the strategies for the diagnosis of respiratory viral infections / S.O. Soloviov, Ya.A. Dzyublyk, O.V. Obertinskaya, I.V. Dzyublyk // Recepe.- 2014.- N 6.- P.119-128.

Belousov, Yu.B. Fundamentals of pharmacoeconomic studies / Yu.B. Belousov, D. Yu. Belousov, V.P. Komarov // Moscow, LLC "Publisher OCI", 2000 - 87 p.

Clinical and economic analysis. The 3d edition, complemented with applications / P.A. Vorobyev, M.V. Avksentieva, O.V. Borisenko [et al.] // M. - Nyudiamed. - 2008. - 778 p.

Human papillomaviruses of high cancer risk in women of different age groups in Ukraine / H.P. Artemchuk, N.Y. Potokiy, O.V. Kovalyuk, I.V. Dzyublyk // Preventive Medicine. - 2014. - N 3-4 (23). - P. 34.

Mathematical modeling of the utility functions for basic strategies of cervical pathology screening / S.O. Soloviov, H.P. Artemchuk, S.M. Kopychko [et al.] // Proceedings of the International Scientific Conference behalf of T.A. Taran "The intellectual analysis of information" (IAI-2015) .- 2015.- P. 225-230.

Downloads

How to Cite

Soloviov, S., Artemchuk, H., Kovalyuk, O., & Dzyublyk, I. (2020). Clinical and epidemiological background of combined strategy for cervical screening of women in Ukraine. Annals of Mechnikov’s Institute, (3), 53–58. Retrieved from https://journals.uran.ua/ami/article/view/193487

Issue

Section

Research Articles